Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis-Reference-Cited by-同舟云学术

Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis

Published:2021-02-23 Issue:1 Volume:12 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Ambati Suresh¹,Ellis Emma C.¹,Pham Tuyetnhu²,Lewis Zachary A.²^ORCID,Lin Xiaorong²^ORCID,Meagher Richard B.¹

Affiliation:

1. Department of Genetics, University of Georgia, Athens, Georgia, USA

2. Department of Microbiology, University of Georgia, Athens, Georgia, USA

Abstract

Invasive aspergillosis (IA) generally results from a pulmonary infection of immunocompromised patients by the common soil organism and opportunistic pathogen Aspergillus fumigatus . The susceptible population has expanded rapidly due to the increased number of cancer patients with immunocompromising chemotherapy and transplant patients taking immunosuppressants.

Funder

University of Georgia

UGA | University of Georgia Research Foundation

HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mBio.00030-21

Reference24 articles.

1. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision